Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
To the Editor: I am troubled by the letter
I received by overnight delivery from Louis Sherwood, MD, Senior Vice President
for US Medical and Scientific Affairs at Merck. He sent a "Dear Healthcare
Provider" letter in response to the article by Dr Mukherjee and colleagues.1 Sherwood directly disparages the article as "not
new" and offers to supplant its findings with Merck's "confidence" in their
product. A full text copy of the package insert was also included.
Sperber K. Cardiovascular Events and COX-2 Inhibitors. JAMA. 2001;286(22):2808-2813. doi:10.1001/jama.286.22.2808